This video by Eric Bricker, MD explains really well why using AI for real-time payments isn't a "no-brainer". There's complex incentives at play. No one wants to eliminate friction when friction itself is the product. youtube.com/watch?v=WBOYDn…

Prediction: more work for doctors that won’t improve patient care one iota.

Johnson & Johnson receives U.S. FDA Priority Review for TAR-200 NDA in high-risk non-muscle invasive bladder cancer jnj.com/media-center/p…

.UnitedHealth Group is seeking monopoly control over health care through systematically purchasing a wide range of health companies, providers, pharmacies, and more, now more than 2,700 entities according to Center for Health and Democracy. Congressman Greg Murphy, M.D. and I are calling for a GAO investigation into

Does the way AI is able to sound so real make it seem like we’re closer to AGI than we actually are?

Variables -Length of obstruction (cm) -Ureteral orifice violation -Ureter compression or invasion -Radiotherapy history #Urology European Association of Urology (EAU)

30 years ago today, I made my Major League debut in Montreal. I got to Olympic Stadium so early they had to find someone to let me in the clubhouse because it was locked.(noon for a 7:30 game) I walked into my first Big League clubhouse and it was just me, all alone. No players,

TO ALL UROLOGISTS (sorry for long tweet but please give it a read) The CMSGov has once again changed some of the RVU values for surgeries and now while I do not perform as many BPH surgeries as I have in the past, I as well as the MAJORITY of practicing urologists, especially

Coverage of our new study Health Affairs by Dave Muoio FierceHealthcare: Hundreds of urban hospitals could be double-dipping into rural Medicare funds, study finds Hundreds of urban hospitals have taken advantage of a 2016 policy change that allows them to be simultaneously

urologytimes.com/view/daniel-d-… Vidit Sharma

JUST IN: IMvigor011 in muscle-invasive bladder cancer (MIBC) hits both DFS & OS with PD-L1 inhibitor Atezolizumab in ctDNA+ population. Major news for Precision Oncology in adjuvant Solid Cancers! Natera Tom Powles Roche natera.com/company/news/i…

A massive betrayal of the 25,000+ Americans who explained to FTC how noncompetes keep people trapped and coerced, undermining basic freedoms. Another clear sign that, despite its rhetoric, this administration is deeply hostile to American workers.

JUST IN: Tar200 now U.S. FDA approved based on SunRise-1 phase 2 trial in BCG unresponsive NMIBC. -Intravesical form of Gemcitabine - CR: 82.4%/grade ≥3 AE 12.9% - DFS 70.2% at 12m - 51% of CRs with DOR ≥ 12 months.

UCLA deserves this. Unbelievable that this is what they destroyed the Pac12 for.

Join us in welcoming Dr. Avi Baskin to UCI! Dr. Baskin's practice emphasizes precision cancer care, minimally invasive techniques, & integration of emerging technologies to improve patient outcomes. We look forward to working with Dr. Baskin to advance the future for cancer care.

Join us in welcoming to Dr. Bruce Gao! Dr. Gao's clinical expertise encompasses the full spectrum of advanced minimally invasive urologic procedures, including HoLEP, PCNL, complex ureteroscopy, and robotic-assisted renal surgery using both single- and multi-port approaches.

As Prostate Cancer Awareness Month ends, we celebrate the vision and launch of the first mobile prostate cancer screening unit of its kind. Keep an eye out for the Van Cave in your community, as we expand access to life-saving screenings and help transform men's health.

Adjuvant RT reduces 2-yr locoregional recurrence to 8% vs 26% with observation (p=0.006) in locally advanced patients post-RC + chemo, with the strongest benefit in T3, T4, and N+ disease. Another piece adding to the discordance: as modern peri-operative NAT drives higher pCR